Jose Hsieh - PharmaEngine Sr Accounting
| 4162 Stock | TWD 92.40 1.70 1.81% |
Executive
Jose Hsieh is Sr Accounting of PharmaEngine
| Phone | 886 2 2515 8228 |
| Web | https://www.pharmaengine.com |
PharmaEngine Management Efficiency
The company has return on total asset (ROA) of 0.0589 % which means that it generated a profit of $0.0589 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0985 %, meaning that it generated $0.0985 on every $100 dollars invested by stockholders. PharmaEngine's management efficiency ratios could be used to measure how well PharmaEngine manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | EXECUTIVE Age | ||
| Sophia Lee | OBI Pharma | N/A | |
| ChengDer Yu | OBI Pharma | N/A | |
| JiannShiun Lai | OBI Pharma | N/A | |
| Amy Huang | OBI Pharma | N/A | |
Management Performance
| Return On Equity | 0.0985 | |||
| Return On Asset | 0.0589 |
PharmaEngine Leadership Team
Elected by the shareholders, the PharmaEngine's board of directors comprises two types of representatives: PharmaEngine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PharmaEngine. The board's role is to monitor PharmaEngine's management team and ensure that shareholders' interests are well served. PharmaEngine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PharmaEngine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jose Hsieh, Sr Accounting | ||
| HongRen Wang, Pres CEO | ||
| Melody Lin, Director HR | ||
| ChiHsing Chang, VP Devel | ||
| Peter Wu, Director Sales |
PharmaEngine Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PharmaEngine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0985 | |||
| Return On Asset | 0.0589 | |||
| Profit Margin | 0.54 % | |||
| Operating Margin | 0.53 % | |||
| Current Valuation | 14.42 B | |||
| Shares Outstanding | 143.69 M | |||
| Shares Owned By Insiders | 22.57 % | |||
| Shares Owned By Institutions | 20.72 % | |||
| Price To Book | 4.72 X | |||
| Price To Sales | 24.13 X |
Pair Trading with PharmaEngine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PharmaEngine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmaEngine will appreciate offsetting losses from the drop in the long position's value.Moving together with PharmaEngine Stock
Moving against PharmaEngine Stock
| 0.8 | 2891C | CTBC Financial Holding | PairCorr |
| 0.8 | 2888 | Shin Kong Financial | PairCorr |
| 0.77 | 6547 | Medigen Vaccine Biologics | PairCorr |
| 0.72 | 6541 | Tanvex BioPharma | PairCorr |
| 0.72 | 4142 | Adimmune Corp | PairCorr |
The ability to find closely correlated positions to PharmaEngine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PharmaEngine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PharmaEngine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PharmaEngine to buy it.
The correlation of PharmaEngine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PharmaEngine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PharmaEngine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PharmaEngine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for PharmaEngine Stock Analysis
When running PharmaEngine's price analysis, check to measure PharmaEngine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaEngine is operating at the current time. Most of PharmaEngine's value examination focuses on studying past and present price action to predict the probability of PharmaEngine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaEngine's price. Additionally, you may evaluate how the addition of PharmaEngine to your portfolios can decrease your overall portfolio volatility.